Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News Briefs: FDA Approves AF Catheter; Tax Reform Proposal; Renal Denervation

This article was originally published in The Gray Sheet

Executive Summary

FDA approved a PMA supplement for Biosense Webster’s Thermocool SmartTouch, the first FDA-approved ablation catheter that can measure contact force in real time. J&J earns a CE mark for its Renlane renal denervation system. More news briefs.

You may also be interested in...



Know Your Force: Study Shows Value Of Contact-Force-Sensing Ablation Catheter

Results of the first major trial evaluating Biosense Webster’s contact-force-sensing ThermoCool SmartTouch catheter show that stability of contact between the ablation catheter and the ablated tissue substantially improves the effectiveness of cardiac ablation for atrial fibrillation, but the average contact force applied during the procedure does not appear to make a difference.

Future Of Renal Denervation On Trial At ACC 2014 This Weekend

The full results of Medtronic’s SYMPLICITY HTN-3 trial, to be presented at the American College of Cardiology Scientific Sessions on March 29, could determine the fate of the renal denervation devices under development by several major companies for drug-resistant hypertension.

News Briefs: Panel OKs Sleep Apnea Stimulator; Two Stryker Buys; TAVR Updates

FDA panel unanimously endorses Inspire upper airway stimulator. Stryker buys Berchtold and Pivot. First randomized U.S. study of embolic protection during transcatheter aortic valve replacement approved. More news.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM003971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel